Source:http://linkedlifedata.com/resource/pubmed/id/20639699
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-8-25
|
pubmed:abstractText |
Beclin 1 plays an important role in autophagy, differentiation, antiapoptosis and the development and progression of cancer. The function and expression of Beclin 1 in natural killer T-cell lymphoma is largely unexplored. The study aimed to investigate Beclin 1 expression and its relationship with prognosis in extranodal natural killer T-cell lymphoma, nasal type (EN KL). Beclin 1 protein expression in 65 tumor specimens from patients newly diagnosed with EN KL was examined by immunohistochemistry (IH C). The clinical significance of Beclin 1 in EN KL was statistically analyzed. Immunopositivity for Beclin 1 was found in 56 (86.2%) of the 65 samples. Low Beclin 1 expression was significantly associated with advanced Ann Arbor stage, intermediate to high IPI risk and elevated LDH level. Low Beclin 1 expression was associated with worse overall survival (OS; p = 0.001) and progression-free survival (PFS; p = 0.017). In multivariate analysis, Beclin1 expression, advanced Ann Arbor stage and B symptoms were found to be independent prognostic factors of OS and PFS. Consequently, a new clinico-pathological prognostic model was proposed. The model could discriminate different survival outcomes between low risk and high risk groups based on OS and PFS (p < 0.0001, respectively). Beclin1 expression is predictive of prognosis in EN KL. The new clinico-pathological prognostic model may be help identify patients with different clinical outcomes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1554-8635
|
pubmed:author |
pubmed-author:HuangHui-QiangHQ,
pubmed-author:HuangJia-JiaJJ,
pubmed-author:HuangYingY,
pubmed-author:JiangWen-QiWQ,
pubmed-author:LiHao-RanHR,
pubmed-author:LiZhi-MingZM,
pubmed-author:LinTong-YuTY,
pubmed-author:LvYueY,
pubmed-author:XiaZhong-JunZJ,
pubmed-author:XuRui-HuaRH,
pubmed-author:ZhuXiao-FengXF
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
777-83
|
pubmed:dateRevised |
2011-6-30
|
pubmed:meshHeading |
pubmed-meshheading:20639699-Adolescent,
pubmed-meshheading:20639699-Adult,
pubmed-meshheading:20639699-Aged,
pubmed-meshheading:20639699-Apoptosis Regulatory Proteins,
pubmed-meshheading:20639699-Disease-Free Survival,
pubmed-meshheading:20639699-Female,
pubmed-meshheading:20639699-Humans,
pubmed-meshheading:20639699-Lymphoma, Extranodal NK-T-Cell,
pubmed-meshheading:20639699-Male,
pubmed-meshheading:20639699-Membrane Proteins,
pubmed-meshheading:20639699-Middle Aged,
pubmed-meshheading:20639699-Models, Biological,
pubmed-meshheading:20639699-Nose Neoplasms,
pubmed-meshheading:20639699-Prognosis,
pubmed-meshheading:20639699-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type.
|
pubmed:affiliation |
State Key Laboratory of Oncology in Southern China, Department of Medical Oncology, Sun Yat-sen University, Guangzhou, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|